(Q38251192)

1 September 2017

0 references

1 reference

title

Brain-derived neurotrophic factor Val66Met polymorphism association with antidepressant efficacy: a systematic review and meta-analysis (English)

1 reference

1 September 2017

1 reference

1 reference

Tingting Yan

1

1 reference

1 September 2017

Lijuan Wang

2

1 reference

1 September 2017

Weihong Kuang

3

1 reference

1 September 2017

Jiajun Xu

4

1 reference

1 September 2017

Suping Li

5

1 reference

1 September 2017

Jie Chen

6

1 reference

1 September 2017

Yanchun Yang

7

1 reference

1 September 2017

18 September 2014

1 reference

1 September 2017

Asia-Pacific Psychiatry

1 reference

1 September 2017

6

1 reference

1 September 2017

3

1 reference

1 September 2017

241-251

1 reference

BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression

1 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Understanding heterogeneity in meta-analysis: the role of meta-regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Antidepressants and neuroplasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Is it time to reassess the BDNF hypothesis of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Association between brain-derived neurotrophic factor 196 G/A polymorphism and personality traits in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Brain-derived neurotrophic factor gene polymorphisms and mirtazapine responses in Koreans with major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Association between the BDNF Val66Met Polymorphism and Chronicity of Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Facilitating clinical implementation of pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

The brain-derived neurotrophic factor is associated with alcohol dependence-related depression and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

BDNF Val66Met genotype and 6-month remission rates in late-life depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

How should meta-regression analyses be undertaken and interpreted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Association study of a brain‐derived neurotrophic‐factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

A splice site polymorphism in the G-protein beta subunit influences antidepressant efficacy in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipran and fluvoxamine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FAPPY.12148

21 January 2018

Identifiers

DOI

10.1111/APPY.12148

1 reference

1 September 2017

1 reference